Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Determining which budgeting method is better depends on your personal financial situation. Explore the options to find your best fit.
22,528 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
When the market sours, many investors reach for bonds. New research suggests this traditional playbook may need rethi...
A bigger 2027 COLA might sound like good news, but two hidden costs could catch retirees off guard. This guide breaks...
Rivian ranks at the bottom of the JD Power 2026 Initial Quality Study, recording 246 problems per 100 vehicles in the...
As markets shift away from giant tech names, a Vanguard built market approach centers on value, dividends, and steady...
DoorDash, Figma, and eBay report after market close, sending shares higher in extended trading. This live blog tracks...
A Jersey Republican is set to reappear in Congress after nearly four months away, citing an unspecified medical condi...
Bitcoin whales boosted holdings by 200,000 BTC in the last 30 days, yet price momentum cooled as underwater traders c...
In 2025, the United States produced a surge of new millionaires, averaging roughly 1,200 per day. The trend lifted th...
President Trump has nominated Kevin Warsh to chair the Federal Reserve, a move that could reshape U.S. monetary polic...
Bank of America Securities projects a new post-crisis peak for non-QM originations in 2026, driven by DSCR and invest...
Imagine turning a modest $100 monthly investment into a meaningful future. This guide breaks down how a stock that co...